Louis Drapeau

Non-Executive Director / Avita Medical

Louis Drapeau has considerable expertise in both the biotech sector and the financial rigour required of US public companies. Based in the US, Mr Drapeau is an independent director at AmphliPhi Biosciences Corporation (NYSE); chief financial officer, principal accounting officer and vice president at Insite Vision; and independent director of at Bio-Rad Laboratories (NYSE). Mr Drapeau held senior positions with Nektar Therapeutics and BioMarin Pharmaceutical, and has been an audit partner at Arthur Andersen. Mr Drapeau has also been an independent director at InterMune (NASDAQ), Bionovo (NASDAQ), and Inflazyme Pharmaceuticals (TSE). He has an MBA from Stanford University.

Lists and Charts

Knowledge Bank : Person Roles

2016

Non-Executive Director

Avita Medical

Year started and most recent title

Total Shareholder Return as at 01/12/25

Rank	Company	1 Yr	5 Yr
1611^th	ECS Botanics Holdings	-69.09%	-27.35%
1612^th	Coronado Global Resources	-69.75%	-19.06%
1613^th	Avita Medical	-69.92%	-27.24%
1614^th	Appen	-69.96%	-51.79%
1615^th	Richmond Vanadium Technology	-69.99%	0%

View Full List

1675 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®

Share Transactions

Person Activity

	REMUNERATION UPDATE: Non-Executive Director, Avita Medical	24 Aug 2020
	REMUNERATION UPDATE: Non-Executive Director, Avita Medical	30 Jun 2020

News Articles

View All

Related Information

Access to our data for Louis Drapeau is only available to paid subscribers with Data & Insights access.

Data & Insights is Western Australia's most accurate and comprehensive business listings and searchable database.

Louis Drapeau is linked to 1 organisation which is included in 1 list - Public Companies - non WA.

To see the data you will need to Subscribe.